1
|
Weinberger J: Diagnosis and prevention of
atherosclerotic cerebral infarction. CNS Spectr. 10:553–564.
2005.PubMed/NCBI
|
2
|
Parmar JP, Rogers WJ, Mugler JP III, et
al: Magnetic resonance imaging of carotid atherosclerotic plaque in
clinically suspected acute transient ischemic attack and acute
ischemic stroke. Circulation. 122:2031–2038. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Binder CJ, Chang MK, Shaw PX, et al:
Innate and acquired immunity in atherogenesis. Nat Med.
8:1218–1226. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hansson GK and Libby P: The immune
response in atherosclerosis: a double-edged sword. Nat Rev Immunol.
6:508–519. 2006. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Li Q, Wang Y, Chen K, et al: The role of
oxidized low-density lipoprotein in breaking peripheral Th17/Treg
balance in patients with acute coronary syndrome. Biochem Biophys
Res Commun. 394:836–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Xie JJ, Wang J, Tang TT, et al: The
Th17/Treg functional imbalance during atherogenesis in ApoE(−/−)
mice. Cytokine. 49:185–193. 2010. View Article : Google Scholar
|
7
|
Haeusler KG, Schmidt WU, Foehring F, et
al: Immune responses after acute ischemic stroke or myocardial
infarction. Int J Cardiol. 155:372–377. 2012. View Article : Google Scholar
|
8
|
Li Q, Wang Y, Yu F, et al: Peripheral
Th17/Treg imbalance in patients with atherosclerotic cerebral
infarction. Int J Clin Exp Pathol. 6:1015–1027. 2013.PubMed/NCBI
|
9
|
Patel P, Mendall MA, Carrington D, et al:
Association of Helicobacter pylori and Chlamydia pneumoniae
infections with coronary heart disease and cardiovascular risk
factors. BMJ. 311:711–714. 1995. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kuo CC, Gown AM, Benditt EP and Grayston
JT: Detection of Chlamydia pneumoniae in aortic lesions of
atherosclerosis by immunocytochemical stain. Arterioscler Thromb.
13:1501–1504. 1993. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kuller LH, Tracy RP, Shaten J and Meilahn
EN: Relation of C-reactive protein and coronary heart disease in
the MRFIT nested case-control study. Multiple Risk Factor
Intervention Trial. Am J Epidemiol. 144:537–547. 1996. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ridker PM, Cushman M, Stampfer MJ, Tracy
RP and Hennekens CH: Inflammation, aspirin, and the risk of
cardiovascular disease in apparently healthy men. New Engl J Med.
336:973–979. 1997. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bataille R and Klein B: C-reactive protein
levels as a direct indicator of interleukin-6 levels in humans in
vivo. Arthritis Rheum. 35:982–984. 1992. View Article : Google Scholar : PubMed/NCBI
|
14
|
Heinrich PC, Castell JV and Andus T:
Interleukin-6 and the acute phase response. Biochem J. 265:621–636.
1990.PubMed/NCBI
|
15
|
Harris TB, Ferrucci L, Tracy RP, et al:
Associations of elevated interleukin-6 and C-reactive protein
levels with mortality in the elderly. Am J Med. 106:506–512. 1999.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Erta M, Quintana A and Hidalgo J:
Interleukin-6, a major cytokine in the central nervous system. Int
J Biol Sci. 8:1254–1266. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Fure B, Wyller TB and Thommessen B: TOAST
criteria applied in acute ischemic stroke. Acta Neurol Scand.
112:254–258. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Alexander RW: Inflammation and coronary
artery disease. N Engl J Med. 331:468–469. 1994. View Article : Google Scholar : PubMed/NCBI
|
20
|
Galis ZS, Sukhova GK, Lark MW and Libby P:
Increased expression of matrix metalloproteinases and matrix
degrading activity in vulnerable regions of human atherosclerotic
plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tappia PS, Troughton KL, Langley-Evans SC
and Grimble RF: Cigarette smoking influences cytokine production
and antioxidant defences. Clin Sci (Lond). 88:485–489. 1995.
|
22
|
Korn T and Petermann F: Development and
function of interleukin 17-producing γδT cells. Ann NY Acad Sci.
1247:34–45. 2012. View Article : Google Scholar
|
23
|
Pang DJ, Neves JF, Sumaria N and
Pennington DJ: Understanding the complexity of γδ T-cell subsets in
mouse and human. Immunology. 136:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Song L and Schindler C: IL-6 and the acute
phase response in murine atherosclerosis. Atherosclerosis.
177:43–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Hashmi S and Zeng QT: Role of
interleukin-17 and interleukin-17-induced cytokines interleukin-6
and interleukin-8 in unstable coronary artery disease. Coron Artery
Dis. 17:699–706. 2006. View Article : Google Scholar : PubMed/NCBI
|